VicapSys Life Sciences Inc.
VICP
ORGANIZATION Vicapsys Life Sciences, Inc. ( VLS or the Company ) was incorporated in the State of Florida on July 8, 1997 under the name All Product Distribution Corp. On August 19, 1998, the Company changed its name to Phage Therapeutics International, Inc.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$1M
▼ -20.0% YoY
Op. Margin
–
ROIC
-8004.19%
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$126K
▼ -75.3% YoY
Net Debt
-$90K
Net Cash Position
Cash & Equiv.
$90K
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with VICP
VicapSys Life Sciences (VICP) in two numbers
Questions about VicapSys Life Sciences
Does VicapSys Life Sciences (VICP) pay a dividend?
No. VicapSys Life Sciences (VICP) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 18 Nov 2024 (period ending 30 Sept 2024), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in VICP's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing VICP
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.